XENE - Xenon Pharmaceuticals Inc
IEX Last Trade
40.32
0.020 0.050%
Share volume: 229,795
Last Updated: Fri 30 Aug 2024 09:59:55 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$40.30
0.02
0.05%
Summary score
15%
Profitability
8%
Dept financing
2%
Liquidity
75%
Performance
10%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 30-Jun-2019 - 30-Jun-2023
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-5.97%
Return on assets
-5.54%
Return on sales
-4153.02%
Return on invested capital
344.44%
Total debt ratio
9.71%
Debt ratio change over timeo
-0.9%
Current Ratio
24.31%
Quick Ratio
30.23%
Cash Position Ratio
22.76%
Short-term ratios 30-Jun-2022 - 30-Jun-2023
The data are presented for the financials results of the quarters of the last year.
Return on equity
-5.89%
Return on assets
-6.4%
Return on sales
-28884.85%
Return on invested capital
-32.49%
Total debt ratio
4.36%
Debt ratio change over timeo
-1.07%
Current Ratio
27.82%
Quick Ratio
27.82%
Cash Position Ratio
27.44%
Last quarter ratios 30-Jun-2023
The data are presented for the financials results of the last quarter.
Return on equity
-7.34%
Return on assets
-8.12%
Return on sales
0%
Return on invested capital
-42.33%
Total debt ratio
5.61%
Debt ratio change over time
-0.92%
Current Ratio
19.34%
Quick Ratio
19.34%
Cash Position Ratio
19.16%
Performance ratios (change over 4 years) 30-Jun-2019 - 30-Jun-2023
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-99.2%
Return on assets
-98.72%
Return on sales
12894.58%
Return on invested capital
-590.19%
Total debt ratio
-89.84%
Debt ratio change over time
-0.9%
Current Ratio
-22.63%
Quick Ratio
-36.99%
Cash Position Ratio
-26.45%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | XENE | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -5.97% | 5.24% | 35.86% | 7.9% |
| Return on assets | -5.54% | 3.12% | 3.56% | 5.95% |
| Return on sales | -4153.02% | 31.5% | 36.15% | 41.33% |
| Return on invested capital | 344.44% | 4.08% | 6.32% | 20.63% |
| Profitability | 25% | 36% | 62% | 57% |
| Total debt ratio | 9.71% | 93.78% | 88.68% | 27.19% |
| Debt ratio change over time | -0.9% | 291.08% | 15.01% | 0.97% |
| Dept financing | 3% | 50% | 25% | 7% |
| Current Ratio | 27.82% | 0.94% | 2.25% | 5.33% |
| Quick Ratio | 27.82% | 0.82% | 1.93% | 4.53% |
| Cash Position Ratio | 27.44% | 0.3% | 1.4% | 2.67% |
| Liquididy | 75% | 3% | 4% | 9% |
| Short-term ratios | XENE | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -5.89% | 14.06% | 44.07% | 4.73% |
| Return on assets | -6.4% | 3.29% | 3.18% | 3.77% |
| Return on sales | -28884.85% | 32% | 34.58% | 34.56% |
| Return on invested capital | -32.49% | 2.77% | 7.32% | 10.76% |
| Profitability | 0% | 59% | 88% | 78% |
| Total debt ratio | 4.36% | 89.22% | 93.78% | 22.11% |
| Debt ratio change over time | -1.07% | 98.45% | 12.55% | 1.14% |
| Dept financing | 1% | 49% | 28% | 6% |
| Current Ratio | 27.82% | 0.94% | 2.25% | 5.33% |
| Quick Ratio | 27.82% | 0.82% | 1.93% | 4.53% |
| Cash Position Ratio | 27.44% | 0.3% | 1.4% | 2.67% |
| Liquididy | 75% | 2% | 5% | 11% |